Tricuspid Regurgitation Stages A to D

Applies the ACC/AHA tricuspid regurgitation stages.

Open the calculator → Runs in your browser. Data leaves only if you deliberately send a problem report from the interactive tool.

Example

Regurgitant volume, severe at 45 or more
50 mL per beat
Systolic flow reversal in the hepatic veins
Yes

Result: stage C

The tool opens with these values already filled in. Replace them with your own.

What the result means

Stage A
At risk: no or trace regurgitation, with a leaflet abnormality or the substrate for a secondary leak - annular dilation, right-sided remodeling, an intracardiac lead.
Stage B
Progressive mild to moderate regurgitation.
Stage C
Asymptomatic severe: jet area 10 square cm or more, vena contracta 0.7 cm or more, orifice 0.40 square cm or more, or volume 45 mL or more.
Stage D
Severe with the signs of right heart failure: ascites, peripheral edema, raised venous pressure, fatigue.
Volume: 45, not 60
Severe here is 45 mL. On the mitral and aortic valves it is 60, so a left-sided figure carried across UNDER-calls a tricuspid leak.
Orifice: 0.40, not 0.30
Severe here is 0.40 square cm, the same as the mitral valve but not the aortic, where 0.30 is already severe. Carried across, that OVER-calls a tricuspid leak.
Hepatic vein reversal
Systolic flow reversal in the hepatic veins commonly accompanies severe regurgitation. Its absence alongside severe numbers is worth reconciling.
Usually secondary
The valve is normal and the ventricle, atrium or a lead has pulled it open. Unlike the mitral valve, that does NOT put it on separate severity criteria.
No C1 or C2
The tricuspid table does not subdivide asymptomatic severe disease on ventricular function the way the mitral and aortic tables do.

What you enter

  • Jet area, severe at 10 or more
  • Vena contracta width, severe at 0.7 or more
  • Effective regurgitant orifice area, severe at 0.40 or more
  • Regurgitant volume, severe at 45 or more
  • Systolic flow reversal in the hepatic veins
  • Mechanism: secondary (normal valve pulled open) or primary (abnormal valve)
  • At-risk valve: leaflet abnormality, annular dilation, right-sided remodeling or a lead
  • Signs of right heart failure
How this is calculated

Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease. Circulation. 2021;143(5):e72-e227. Read the source ↗

A reference and educational tool. Not medical, legal, or financial advice, and not a substitute for clinician judgment.

Browse all tools

Built by Clay Good. Source on GitHub.